Soligenix logo
Soligenix logo

Soligenix

soligenix.com
soligenix.com • HQ: Princeton, United States • Venture - Series Unknown 2017 • 1-10 employees
HQ: Princeton, United States • Venture - Series Unknown 2017 • 1-10 employees
Actively hiring
Rare Disease Therapeutics
Biologics & Biosimilars
Health Care
Follow
Overview
Salaries
Products
People
Growth
Offices
Financials

Overview

Soligenix is a late-stage biopharmaceutical company that develops and commercializes products that treat rare diseases.

People

Adam Rumage
Executive Officer
SEC Form D
Richard Straube MD MSc
Executive Officer
SEC Form D
Karen Krumeich
Executive Officer
SEC Form D
Oreola Donini PhD
Executive Officer
SEC Form D
R. Cavalli PhD
Executive Officer
SEC Form D
Christopher Schaber PhD
Executive Officer, Director
SEC Form D
Keith Brownlie CPA
Director
SEC Form D
Jerome Zeldis PhD
Director
SEC Form D
Gregg LaPointe CPA
Director
SEC Form D
Robert Rubin MD
Director
SEC Form D
Marco Brughera DVM
Director
SEC Form D
Names and roles come from public filings, company registers and the company's own site. Is this you? Correct or remove

Offices

Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
Princeton United States
HQ
Comments
1-10 est. staff
29 Emmons Drive Suite B-10, Princeton, NJ 08540
company site

Financials

Total raised
$2M
Latest round
Venture - Series Unknown
Funding rounds
1
Funding rounds
Round Announced Amount
Venture - Series Unknown 2017 $2M Details